Comparative molecular field analysis of some pyridazinone-containing α1-antagonists

Bioorganic and Medicinal Chemistry

Volumn 7, Issue 11, 1999, Pages 2615-2620

  Cinone, N ^a   Carrieri, A ^a   Strappaghetti, G ^b   Corsano, S ^b   Barbaro, R ^b   Carotti, A ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

1 Adrenoceptor antagonists; 3 D QSAR study; Piperazine pyridazinones

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; NORADRENALIN; PYRIDAZINONE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CONFORMATION; DRUG SYNTHESIS; EPIDIDYMIS; MOLECULAR MODEL; NONHUMAN; PHARMACOPHORE; PHYSICAL CHEMISTRY; RAT; REGRESSION ANALYSIS; STRUCTURE ACTIVITY RELATION; VAS DEFERENS;

ADRENERGIC ALPHA-ANTAGONISTS; MODELS, MOLECULAR; PYRIDAZINES; RECEPTORS, ADRENERGIC, ALPHA-1; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA;

EID: 0033492377     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(99)00211-4     Document Type: Article

References (21)

1. Kasztreiner E., Màtyus P., Rabloczky G., Jaszlits L. Drugs Future. 14:1989;622.
2. Beduschi R., Beduachi M.C., Oesterling J. Geriatrics. 53:1998;24.
3. Gunderman T., Nurnberg B., Schultz G. J. Mol Med. 73:1995;51.
4. Hieble J.P., Bondinell W.E., Ruffolo R.R. J. Med. Chem. 38:1995;3415.
5. Hieble J.P., Bylund D.B., Clerke D.E., Eikenberg D.C., Langer S.Z., Lefkowitz R.T., Minneman K.P., Ruffolo R.R. Pharmacol Rev. 47:1995;267.
6. Corsano S., Strappaghetti G., Codagnone A. Arch. Pharm. 322:1989;833.
7. Corsano S., Strappaghetti G., Leonardi A., Rhazri K., Barbaro R. Eur. J. Med. Chem. 32:1997;339.
8. Corsano S., Scapicchi R., Strappaghetti G., Marucci G., Paparelli F. Eur. J. Med. Chem. 28:1993;647.
9. Corsano S., Scapicchi R., Strappaghetti G., Marucci G., Paparelli F. Eur. J. Med. Chem. 30:1995;71.
10. Montesano F., Barlocco D., Del Piaz V., Leonardi A., Poggesi E., Fanelli F., De Benedetti P.G. Bioorg. Med. Chem. 6:1998;925.
11. Cramer R.D., Patterson D.E., Bunce J.D. J. Am. Chem. Soc. 110:1988;5959.
12. Cramer, R. D.; De Prierst, S. A.; Patterson, D. E.; Hect, P. In 3D-QSAR in Drug design: Theory, methods and applications; Kubinyi, H., Ed.; Escom: Leiden, 1993, pp 443-485.
13. Dunn W.J.III., Wold S., Edlund U., Helberg S. Quant. Struct. -Act. Relat. 3:1984;131.
14. Wold, S.; Johansson, E.; Cocchi, M. in ref 13, pp 523-549.
15. Cramer R.D.III., Bunce J.D., Patterson D.E. Quant. Struct. -Act. Relat. 7:1988;18.
16. Tripos Assoc. St. Louis, MO, USA
17. Allen F.H., Kennard O. Chem. Des. News. 1:1993;31.
18. Gaillard P., Carrupt P.A., Testa B., Schambel P. J. Med. Chem. 39:1996;126.
19. AM1 and PM3 quantomechanical semiempirical methods can be found on the package MOPAC 6.0 which is available from QCPE (506).
20. Clark M., Cramer R.D.III., Jones D.M., Patterson D.E., Simeroth P. Tetrahedron Comput. Methodol. 3:1990;47.
21. Drew G.M. Eur. J. Pharmacol. 27:1977;123.